Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Rheumatoid Arthritis(RA)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT00319917
What this trial is testing

A Double Blind Placebo Controlled Study to Assess the Efficacy on Joint Damage in RA Patients

Who this might be right for
Rheumatoid Arthritis
Astellas Pharma Inc 123
Testing effectiveness (Phase 2)Study completedNCT03239080
What this trial is testing

Effect of Denosumab in Erosion Healing in RA

Who this might be right for
Rheumatoid Arthritis
Chinese University of Hong Kong 110
Not applicableStudy completedNCT01671059
What this trial is testing

A Non-Interventional Study Evaluating Rheumatoid Arthritis Participants Treated With Tocilizumab (RoActemra/Actemra)

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 80
Not applicableNot Yet RecruitingNCT07796841
What this trial is testing

GAS5 Gene Expression and IL-6 in Rheumatoid Arthritis

Who this might be right for
RA - Rheumatoid Arthritis
Sohag University 50
Not applicableStudy completedNCT04340115
What this trial is testing

Study To Assess Frequency Of Serious Infections In Clinical Practice In Japan For Adult Participants With Rheumatoid Arthritis Receiving Oral RINVOQ Tablets

Who this might be right for
Rheumatoid Arthritis (RA)
AbbVie 4,211
Testing effectiveness (Phase 2)Study completedNCT00280917
What this trial is testing

Oral CF101 and Methotrexate Treatment in Rheumatoid Arthritis Patients

Who this might be right for
Rheumatoid Arthritis
Can-Fite BioPharma 254
Large-scale testing (Phase 3)Ended earlyNCT00485589
What this trial is testing

Ocrelizumab in Combination With Methotrexate in Patients With Rheumatoid Arthritis Who Are Naive to Methotrexate (FILM)

Who this might be right for
Rheumatoid Arthritis
Genentech, Inc. 613
Not applicableStudy completedNCT04772248
What this trial is testing

Safety of TofAcitinib in Routine Care Patients With Rheumatoid Arthritis (STAR-RA)- Cardiovascular Endpoints

Who this might be right for
Rheumatoid Arthritis
Brigham and Women's Hospital 105,711
Large-scale testing (Phase 3)Study completedNCT02760368
What this trial is testing

Evaluation of the Effectiveness and Safety of Two Dosing Regimens of Olokizumab (OKZ), Compared to Placebo, in Subjects With Rheumatoid Arthritis (RA) Who Are Taking Methotrexate But Have Active Disease

Who this might be right for
Rheumatoid Arthritis
R-Pharm International, LLC 428
Large-scale testing (Phase 3)Study completedNCT03147248
What this trial is testing

A Phase I/III Study to Evaluate Efficacy, PK and Safety Between CT-P13 SC and CT-P13 IV in Patients With Active RA

Who this might be right for
Rheumatoid Arthritis
Celltrion 407
Testing effectiveness (Phase 2)Study completedNCT00903383
What this trial is testing

Study of LX3305 in Subjects With Active Rheumatoid Arthritis on Stable Methotrexate

Who this might be right for
Rheumatoid Arthritis
Lexicon Pharmaceuticals 208
Post-approval studies (Phase 4)Study completedNCT01224041
What this trial is testing

Study to Evaluate the Efficacy of Tacrolimus in Rheumatoid Arthritis Patients Shown Unsuccessful Response to Methotrexate

Who this might be right for
Rheumatoid Arthritis
Astellas Pharma Inc 78
Early research (Phase 1)Ended earlyNCT01390441
What this trial is testing

The Pharmacokinetics and Safety of MK-8808 (MK-8808-002)

Who this might be right for
Rheumatoid Arthritis
Merck Sharp & Dohme LLC 100
Large-scale testing (Phase 3)Study completedNCT01347983
What this trial is testing

Extension Study of Tocilizumab Long Term Treatment of Moderate to Severe Rheumatoid Arthritis Patients

Who this might be right for
Rheumatoid Arthritis
Chugai Pharma Taiwan 72
Early research (Phase 1)Looking for participantsNCT07607964
What this trial is testing

Assess Adverse Events, How the Drug Moves Through the Body and Effectiveness of Intravenous Infusions and Subcutaneous Injections of ABBV-519 in Adult Participants With Systemic Lupus Erythematosus (SLE) or Rheumatoid Arthritis (RA)

Who this might be right for
Systemic Lupus ErythematosusRheumatoid Arthritis
AbbVie 30
Large-scale testing (Phase 3)Study completedNCT01662063
What this trial is testing

A Long-Term Extension Study of WA22762 and NA25220 of Subcutaneous (SC) Tocilizumab (TCZ) in Moderate to Severe Rheumatoid Arthritis (RA)

Who this might be right for
Rheumatoid Arthritis
Genentech, Inc. 218
Large-scale testing (Phase 3)Study completedNCT01326962
What this trial is testing

RoActemra/Actemra (Tocilizumab) in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to DMARDs or Anti-TNF

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 28
Large-scale testing (Phase 3)Study completedNCT01377012
What this trial is testing

Efficacy at 24 Weeks and Safety, Tolerability and Long Term Efficacy up to 2 Years of Secukinumab (AIN457) in Patients With Active Rheumatoid Arthritis and an Inadequate Response to Anti-TNFα Agents

Who this might be right for
Rheumatoid Arthritis
Novartis Pharmaceuticals 637
Not applicableLooking for participantsNCT07463937
What this trial is testing

A RWS of SC MTX in Chinese RA Patients

Who this might be right for
Rheumatoid Arthritis (RA)
Peking University People's Hospital 10,000
Post-approval studies (Phase 4)Study completedNCT01554917
What this trial is testing

Iguratimod in Patients With Active Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Jiangsu Simcere Pharmaceutical Co., Ltd. 1,759
Next Page